# Dexmedetomidine-based Sedation in Neurocritical Care Patients

> **NCT02252523** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 66 (estimated)

## Conditions studied

- Acute Brain Injuries

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02252523
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2014-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02252523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02252523, "Dexmedetomidine-based Sedation in Neurocritical Care Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02252523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*